Percutaneous radiofrequency nerve ablation in patients with chronic heel pain
Archives of Current Medical Research · 2022
DOI: 10.47482/acmr.1111650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Current Medical Research, 2022. Verfasst von Mesut TIKMAN und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Heel pain, known as fasciitis, runner’s heel, tennis heel, or police heel, can sometimes become challenging to manage. Many conservative methods, including stretching or orthosis, steroid injection, and extracorporeal shock wave therapy, are used in treating heel pain. This study investigated the therapeutic effect of percutaneous radiofrequency nerve ablation (RFNA) in treating patients with chronic heel pain.
Methods
In this retrospective study, 78 (84 feet) patients with severe and chronic heel pain were included. Patients with heel pain related to calcaneal spur were resistant to conservative methods. Therefore, RFNA was performed on patients who met the criteria. Patients were assessed with a questionnaire and the visual analog scale (VAS) before and after the procedure.
Results
The mean VAS results were 9.3 ± 0.8 before and 3.4 ± 2.6 six months after the procedure, with statistically significant change observed. (p<0.05) Furthermore, 79.2% of participants found RFNA favorable.
Conclusions
According to the findings, we may say that RFNA successfully relieves chronic heel pain.
Zitieren
APA
TIKMAN, M., & DUMAN, E. (2022). Percutaneous radiofrequency nerve ablation in patients with chronic heel pain. Archives of Current Medical Research. https://doi.org/10.47482/acmr.1111650
Vancouver
TIKMAN M, DUMAN E. Percutaneous radiofrequency nerve ablation in patients with chronic heel pain. Archives of Current Medical Research. 2022. doi:10.47482/acmr.1111650
BibTeX
@article{TIKMAN2022,
author = {TIKMAN, Mesut and DUMAN, Evrim},
title = {Percutaneous radiofrequency nerve ablation in patients with chronic heel pain},
journal = {Archives of Current Medical Research},
year = {2022},
doi = {10.47482/acmr.1111650}
}
EUVIMED